Abstract:BACKGROUND & AIMS:Esophageal squamous cell carcinoma (ESCC) is the most common subtype of esophageal cancer. Little is known about the genetic changes that occur in esophageal cells during the development of ESCC. We performed next-generation sequence analyses of esophageal nontumor, intraepithelial neoplasia (IEN), and ESCC tissues from the same patients to track genetic changes during tumor development.METHODS:We performed whole-genome, whole-exome, or targeted sequence analyses of 227 esophageal tissue samples from 70 patients with ESCC undergoing resection at Shantou University Medical College in China from 2012 through 2015 (no patients had received chemotherapy or radiation therapy); we analyzed normal tissues, tissues with simple hyperplasia, dysplastic tissues (IEN), and ESCC tissues collected from different regions of the esophagus at the same time. We also obtained 1191 nontumor esophageal biopsy specimens from the Chaoshan region (a high-risk region for ESCC) of China (a high-risk region for ESCC) and performed immunohistochemical and histologic analyses to detect inflammation.RESULTS:IEN and ESCC tissues had similar mutations and copy number alterations, at similar frequencies; these differed from mutations detected in tissues with simple hyperplasia. IEN tissues had mutations associated with apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like-mediated mutagenesis (a DNA damage mutational signature). Genetic analyses indicated that most ESCCs were formed from early stage IEN clones. Trunk mutations (mutations shared by >10% of paired IEN and ESCC tissues) were in genes that regulate DNA repair and cell apoptosis, proliferation and adhesion. Mutations in TP53 and CDKN2A and copy number alterations in 11q (contains CCND1), 3q (contains SOX2), 2q (contains NFE2L2), and 9p (contains CDKN2A) were considered to be trunk variants; these were dominant mutations detected at high frequencies in clones of paired IEN and ESCC samples. In the esophageal biopsy samples from high-risk individuals (residing in the Chaoshan region), 68.9% had an evidence of chronic inflammation; the level of inflammation was correlated with atypical cell structures and markers of DNA damage.CONCLUSIONS:We analyzed mutations and gene copy number changes in nontumor, IEN, and ESCC samples, collected from 70 patients. IEN and ESCCs each had similar mutations and markers of genomic instability, including apolipoprotein B messenger RNA editing enzyme, catalytic polypeptide-like. Genomic changes observed in precancerous lesions might be used to identify patients at risk for ESCC.

Aneuploid Analysis of Chromosomes 3, 8, 10, 20 and Y in Esophageal Squamous Cell Carcinoma

Identification of chromosome aberrations in esophageal cancer cell line KYSE180 by multicolor fluorescence in situ hybridization.

Application of Multicolor Fluorescence in Situ Hybridization to Early Diagnosis of Esophageal Squamous Cell Carcinoma

Characterization of Genetic Rearrangements in Esophageal Squamous Carcinoma Cell Lines by a Combination of M-FISH and Array-Cgh: Further Confirmation of Some Split Genomic Regions in Primary Tumors

Cytogenetic and Fluorescence in Situ Hybridization Characterization of Clonal Chromosomal Aberrations and CCND1 Amplification in Esophageal Carcinomas

Chromosomal Aneuploidies and Combinational Fluorescence in Situ Hybridization Probe Panels Are Useful for Predicting Prognosis for Esophageal Squamous Cell Carcinoma

Identification of complex chromosome abnormalities in esophageal carcinoma cells KYSE450 by multicolor fluorescence in situ hybridization

Prevalence of Gene Amplifications of Sox-2, C-Met, and Fgfr1 in Asian Patients with Esophageal Squamous Cell Carcinoma.

Cytogenetic Studies of Esophageal Squamous Cell Carcinomas in the Northern Chinese Population by Comparative Genomic Hybridization

Characterization of Gene Rearrangements Resulted from Genomic Structural Aberrations in Human Esophageal Squamous Cell Carcinoma KYSE150 Cells.

Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.

Consistent and Differential Genetic Aberrations Between Esophageal Dysplasia and Squamous Cell Carcinoma Detected by Array Comparative Genomic Hybridization.

The Prognostic Value of EGFR Overexpression and Amplification in Esophageal Squamous Cell Carcinoma

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

Genomic alterations with impact on survival in esophageal squamous cell carcinoma identified by array comparative genomic hybridization.

Comparative Genomic Hybridization Of Esophageal Adenocarinoma And Squamous Cell Carcinoma Cell Lines

Genome-wide Screening for Genomic Aberrations in Kazakh Patients with Esophageal Squamous Cell Cancer by Comparative Genomic Hybridization.

Detection of CCND1 Amplification Using Laser Capture Microdissection Coupled with Real-Time Polymerase Chain Reaction in Human Esophageal Squamous Cell Carcinoma

Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: Copy Number Alteration Gene Identification and Cfdna Detection.

Genetic Alterations in Esophageal Tissues from Squamous Dysplasia to Carcinoma.